Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats

Abstract Background More evidence suggests that dorsal spinal cord microglia is an important site contributing to CB2 receptor-mediated analgesia. The upregulation of P2Y12 and P2Y13 purinoceptors in spinal dorsal horn microglia is involved in the development of pain behavior caused by peripheral ne...

Full description

Bibliographic Details
Main Authors: Juan Niu, Dujuan Huang, Rui Zhou, MingXia Yue, Tao Xu, Junna Yang, Li He, Hong Tian, XiaoHong Liu, Junwei Zeng
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-017-0960-0
_version_ 1818266418891718656
author Juan Niu
Dujuan Huang
Rui Zhou
MingXia Yue
Tao Xu
Junna Yang
Li He
Hong Tian
XiaoHong Liu
Junwei Zeng
author_facet Juan Niu
Dujuan Huang
Rui Zhou
MingXia Yue
Tao Xu
Junna Yang
Li He
Hong Tian
XiaoHong Liu
Junwei Zeng
author_sort Juan Niu
collection DOAJ
description Abstract Background More evidence suggests that dorsal spinal cord microglia is an important site contributing to CB2 receptor-mediated analgesia. The upregulation of P2Y12 and P2Y13 purinoceptors in spinal dorsal horn microglia is involved in the development of pain behavior caused by peripheral nerve injury. However, it is not known whether the expression of P2Y12 and P2Y13 receptors at spinal dorsal horn will be influenced after CB2 receptor activation in neuropathic pain rats. Methods Chronic constriction injury (CCI) and intrathecal ADPbetaS injection were performed in rats to induce neuropathic pain. The paw withdrawal latency (PWL) was used to evaluate thermal hyperalgesia in neuropathic rats. The expression of P2Y12 and P2Y13 receptors, p-p38MAPK, and NF-kappaBp65 was detected with RT-PCR and western blotting analysis. Results Treatment with AM1241 produces a pronounced inhibition of CCI-induced thermal hyperalgesia and significantly inhibited the increased expression of P2Y12 and P2Y13 receptors at the mRNA and protein levels, which open up the possibility that P2Y12 and P2Y13 receptor expression are downregulated by CB2 receptor agonist AM1241 in CCI rats. Western blot analysis demonstrated that AM1241 reduced the elevated expression of p-p38MAPK and NF-κBp65 in the dorsal spinal cord induced by CCI. After administration with either SB203580 (p38MAPK inhibitor) or PDTC (NF-kappaB inhibitor), the levels of P2Y13 receptor expression in the dorsal spinal cord were lower than those in the CCI group. However, in CCI rats, the increased expression of P2Y12 receptor was prevented by intrathecal administration of PDTC but not by SB203580. In addition, minocycline significantly decreased the increased expression of P2Y12 and P2Y13 receptors. The similar results can be observed in ADPbetaS-treated rats. Intrathecal injection of ADPbataS causes thermal hyperalgesia and increased expression of P2Y12 and P2Y13 receptors in the dorsal spinal cord of naive rats. Moreover, intrathecal injection of AM1241 alleviates pain response and reduces the elevated expression of P2Y12 and P2Y13 receptors, p-p38MAPK, and NF-κBp65 in the dorsal spinal cord of ADPbetaS-treated rats. Intrathecal injection of SB203580 significantly inhibited the ADPbetaS-induced P2Y13 receptor expression, without affecting P2Y12 receptor expression. However, treatment with either SB203580 or PDTC effectively inhibited P2Y13 receptor expression compared to ADPbetaS-treated rats. Conclusions In CCI- and ADPbetaS-treated rats, AM1241 pretreatment could efficiently activate CB2 receptor, while inhibiting p38MAPK and NF-kappaB activation in the dorsal spinal cord. CB2 receptor stimulation decreased P2Y13 receptor expression via p38MAPK/NF-kappaB signaling. On the other hand, CB2 receptor activation decreased P2Y12 receptor expression via p38MAPK-independent NF-kappaB signaling pathway.
first_indexed 2024-12-12T20:06:24Z
format Article
id doaj.art-8e527eaf635c47e787cce353466bbacb
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-12-12T20:06:24Z
publishDate 2017-09-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-8e527eaf635c47e787cce353466bbacb2022-12-22T00:13:37ZengBMCJournal of Neuroinflammation1742-20942017-09-0114111210.1186/s12974-017-0960-0Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain ratsJuan Niu0Dujuan Huang1Rui Zhou2MingXia Yue3Tao Xu4Junna Yang5Li He6Hong Tian7XiaoHong Liu8Junwei Zeng9Department of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeDepartment of Physiology, Zunyi Medical CollegeAbstract Background More evidence suggests that dorsal spinal cord microglia is an important site contributing to CB2 receptor-mediated analgesia. The upregulation of P2Y12 and P2Y13 purinoceptors in spinal dorsal horn microglia is involved in the development of pain behavior caused by peripheral nerve injury. However, it is not known whether the expression of P2Y12 and P2Y13 receptors at spinal dorsal horn will be influenced after CB2 receptor activation in neuropathic pain rats. Methods Chronic constriction injury (CCI) and intrathecal ADPbetaS injection were performed in rats to induce neuropathic pain. The paw withdrawal latency (PWL) was used to evaluate thermal hyperalgesia in neuropathic rats. The expression of P2Y12 and P2Y13 receptors, p-p38MAPK, and NF-kappaBp65 was detected with RT-PCR and western blotting analysis. Results Treatment with AM1241 produces a pronounced inhibition of CCI-induced thermal hyperalgesia and significantly inhibited the increased expression of P2Y12 and P2Y13 receptors at the mRNA and protein levels, which open up the possibility that P2Y12 and P2Y13 receptor expression are downregulated by CB2 receptor agonist AM1241 in CCI rats. Western blot analysis demonstrated that AM1241 reduced the elevated expression of p-p38MAPK and NF-κBp65 in the dorsal spinal cord induced by CCI. After administration with either SB203580 (p38MAPK inhibitor) or PDTC (NF-kappaB inhibitor), the levels of P2Y13 receptor expression in the dorsal spinal cord were lower than those in the CCI group. However, in CCI rats, the increased expression of P2Y12 receptor was prevented by intrathecal administration of PDTC but not by SB203580. In addition, minocycline significantly decreased the increased expression of P2Y12 and P2Y13 receptors. The similar results can be observed in ADPbetaS-treated rats. Intrathecal injection of ADPbataS causes thermal hyperalgesia and increased expression of P2Y12 and P2Y13 receptors in the dorsal spinal cord of naive rats. Moreover, intrathecal injection of AM1241 alleviates pain response and reduces the elevated expression of P2Y12 and P2Y13 receptors, p-p38MAPK, and NF-κBp65 in the dorsal spinal cord of ADPbetaS-treated rats. Intrathecal injection of SB203580 significantly inhibited the ADPbetaS-induced P2Y13 receptor expression, without affecting P2Y12 receptor expression. However, treatment with either SB203580 or PDTC effectively inhibited P2Y13 receptor expression compared to ADPbetaS-treated rats. Conclusions In CCI- and ADPbetaS-treated rats, AM1241 pretreatment could efficiently activate CB2 receptor, while inhibiting p38MAPK and NF-kappaB activation in the dorsal spinal cord. CB2 receptor stimulation decreased P2Y13 receptor expression via p38MAPK/NF-kappaB signaling. On the other hand, CB2 receptor activation decreased P2Y12 receptor expression via p38MAPK-independent NF-kappaB signaling pathway.http://link.springer.com/article/10.1186/s12974-017-0960-0CB2 receptorP2Y12 receptorP2Y13 receptorDorsal spinal cordMicrogliaNeuropathic pain
spellingShingle Juan Niu
Dujuan Huang
Rui Zhou
MingXia Yue
Tao Xu
Junna Yang
Li He
Hong Tian
XiaoHong Liu
Junwei Zeng
Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats
Journal of Neuroinflammation
CB2 receptor
P2Y12 receptor
P2Y13 receptor
Dorsal spinal cord
Microglia
Neuropathic pain
title Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats
title_full Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats
title_fullStr Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats
title_full_unstemmed Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats
title_short Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12 and P2Y13 receptors in neuropathic pain rats
title_sort activation of dorsal horn cannabinoid cb2 receptor suppresses the expression of p2y12 and p2y13 receptors in neuropathic pain rats
topic CB2 receptor
P2Y12 receptor
P2Y13 receptor
Dorsal spinal cord
Microglia
Neuropathic pain
url http://link.springer.com/article/10.1186/s12974-017-0960-0
work_keys_str_mv AT juanniu activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT dujuanhuang activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT ruizhou activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT mingxiayue activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT taoxu activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT junnayang activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT lihe activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT hongtian activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT xiaohongliu activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats
AT junweizeng activationofdorsalhorncannabinoidcb2receptorsuppressestheexpressionofp2y12andp2y13receptorsinneuropathicpainrats